James Patrick Kelly - Aug 16, 2021 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
EVP, CFO and Treasurer
Signature
/s/ John A. Herrmann III, Attorney-in-Fact
Stock symbol
NVAX
Transactions as of
Aug 16, 2021
Transactions value $
$0
Form type
4
Date filed
8/18/2021, 05:16 PM
Next filing
Mar 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Award $0 +7.1K $0.00 7.1K Aug 16, 2021 Common Stock 7.1K Direct F1, F2
transaction NVAX Stock Option (Right to Buy) Award $0 +14.2K $0.00 14.2K Aug 16, 2021 Common Stock 14.2K $229.31 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
F2 One-third (1/3) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on each of the first three (3) anniversaries of the August 16, 2021 grant date (the "Grant Date"), subject to continued employment through each such vesting date.
F3 Twenty-five percent (25%) of the shares subject to this option grant under the Plan will vest on the first anniversary of the Grant Date, and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.